Skip to content

Drug interactions

Pasireotide + Solifenacin

Severity: Moderate

Pasireotide and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pasireotide and solifenacin can each prolong the QT interval, so combining them may raise the risk of serious ventricular arrhythmia. Pasireotide also causes bradycardia, which adds to the risk.

What this interaction means in plain words

Pasireotide and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pasireotide belongs to Endocrine; Solifenacin belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Additive QT prolongation, with pasireotide-related bradycardia increasing arrhythmia susceptibility.

What to do

Check baseline ECG and electrolytes, and correct hypokalemia and hypomagnesemia. Monitor QTc periodically during co-therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pasireotide and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pasireotide with Solifenacin?

MediHelp rates the interaction as moderate. Pasireotide and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pasireotide and solifenacin can each prolong the QT interval, so combining them may raise the risk of serious ventricular arrhythmia. Pasireotide also causes bradycardia, which adds to the risk.

How serious is the interaction between Pasireotide and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check baseline ECG and electrolytes, and correct hypokalemia and hypomagnesemia. Monitor QTc periodically during co-therapy.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in